Apotek Produktion & Laboratorier AB (APL) Fresenius Kabi Austria GmbH

The medicine is used to reduce blood loss and limit the need for blood transfusion during and after heart surgery. It is intended for patients at increased risk of heavy blood loss who are to undergo heart bypass surgery using cardiopulmonary bypass.

Dosage form: solution for infusion

ATC: B02AB01